v3.21.1

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Assets
Cash and cash equivalents	$ 458,101	$ 486,752
Accounts receivable, net	84,947	71,168
Inventory	137,627	129,138
Prepaid expenses and other current assets	38,058	42,472
Total current assets	718,733	729,530
Property, plant, and equipment, net	149,591	143,767
Operating lease assets	24,036	25,118
Intangible assets, net	5,271	5,565
Goodwill	6,959	6,959
Deferred tax assets	20,775	20,777
Other assets	8,978	7,795
Total assets	934,343	939,511
Liabilities and stockholders’ equity
Accounts payable	16,672	21,870
Accrued liabilities	136,101	127,849
Current tax liabilities	420	877
Other current liabilities	7,053	9,210
Total current liabilities	160,246	159,806
Long-term liabilities:
Finance lease liabilities	5,413	5,454
Operating lease liabilities	21,373	22,127
Other liabilities	10,938	11,034
Total long-term liabilities	37,724	38,615
Total liabilities	197,970	198,421
Commitments and contingencies (Note 8)
Stockholders’ equity:
Ordinary shares par value £0.001; 378,505,496 shares outstanding as of March 31, 2021; 375,196,172 shares outstanding as of December 31, 2020	583	577
Additional paid-in capital	1,702,578	1,690,151
Accumulated deficit	(915,764)	(896,087)
Accumulated other comprehensive loss	(51,024)	(53,551)
Total stockholders’ equity	736,373	741,090
Total liabilities and stockholders’ equity	$ 934,343	$ 939,511

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

GW PHARMACEUTICALS PLC 10-Q